Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents

Journal of the American College of Cardiology

Volumn 44, Issue 4, 2004, Pages 864-868

  Hongo, Richard H ^a   Themistoclakis, Sakis ^b   Raviele, Antonio ^b   Bonso, Aldo ^b   Rossillo, Antonio ^b   Glatter, Kathryn A ^c   Yang, Yanfei ^a   Scheinman, Melvin M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Umberto I Hospital   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; FLECAINIDE; IBUTILIDE; MAGNESIUM; PROPAFENONE;

ADULT; AGED; ARTICLE; CARDIOVERSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG USE; ELECTRIC SHOCK; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART LEFT VENTRICLE CONTRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QT INTERVAL; TORSADE DES POINTES;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FEMALE; FLECAINIDE; HEART CONDUCTION SYSTEM; HUMANS; ITALY; MALE; MIDDLE AGED; PROPAFENONE; PROSPECTIVE STUDIES; SAN FRANCISCO; SULFONAMIDES; TREATMENT OUTCOME;

EID: 4243118731     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.05.051     Document Type: Article

References (14)

1. V. Fuster, L.E. Ryden, R.W Asinger ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) J Am Coll Cardiol 38 2001 1266ilxx
2. A. Nabar, L.M. Rodriguez, C. Timmermans, J.L. Smeets, H.J. Wellens Radiofrequency ablation of class IC atrial flutter in patients with resistant atrial fibrillation Am J Cardiol 83 1999 785 787
3. B.S. Stambler, M.A. Wood, K.A. Ellenbogen Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation electrophysiological determinants of enhanced conversion efficacy Circulation 96 1997 4298 4306
4. M.A. Vos, S.R. Golitsyn, K Stangl Superiority of ibutilide over DL-sotalol in converting atrial flutter and atrial fibrillation Heart 79 1998 568 575
5. A.S. Volgman, P.A. Carberry, B Stambler Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation J Am Coll Cardiol 31 1998 1414 1419
6. J.A. Reiffel, M. Blitzer The actions of ibutilide and class IC drugs on the slow sodium channel new insights regarding individual pharmacologic effects elucidated through combination therapies J Cardiovasc Pharmacol Ther 5 2000 177 181
7. Kr) in AT-1 cells Circulation 91 1995 1799 1806
8. K.S. Lee, E.W. Lee Ionic mechanism of ibutilide in human atrium evidence for a drug-induced Na+ current through a nifedipine inhibited inward channel J Pharmacol Exp Ther 286 1998 9 22
9. K.A. Ellenbogen, B.S. Stambler, M.A Wood Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter a dose-response study J Am Coll Cardiol 28 1996 130 136
10. B.S. Stambler, M.A. Wood, K.A. Ellenbogen, K.T. Perry, L.K. Wakefield, J.T. VanderLugt Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation Circulation 94 1996 1613 1621
11. P. Abi-Mansour, P.A. Carberry, R.J. McCowan, R.W. Henthorn, G.H. Dunn, K.T. Perry Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation Am Heart J 136 1998 632 642
12. K. Glatter, Y. Yang, K Chatterjee Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy Circulation 103 2001 253 257
13. P.R. Kowey, J.T. VanderLugt, J.R. Luderer Safety and risk/benefit analysis of ibutilide for acute conversion of atrial fibrillation/flutter Am J Cardiol 78 1996 46 52
14. B.S. Stambler, K.J. Beckman, A.H Kadish Acute hemodynamic effects of intravenous ibutilide in patients with or without reduced left ventricular function Am J Cardiol 80 1997 458 463